Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K
Skin Cancer01:30

Skin Cancer

4.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From clinical genetics to genomic-based public health screening programmes: duty-based ethics as a guide for responsible implementation.

European journal of human genetics : EJHG·2026
Same author

Germline genomic testing to assess the suitability of stem cell donors in the treatment of haematological malignancy: clinical ethics commentary.

Journal of medical ethics·2025
Same author

Multiple outcomes of the germline p16<sup>INK4a</sup> mutation affecting senescence and immunity in human skin.

Aging cell·2024
Same author

Identification and functional validation of a novel pathogenic <i>POT1</i> germline variant p.G95V in familial melanoma.

JEADV clinical practice·2024
Same author

Reproductive decision-making in cancer susceptibility syndromes.

Best practice & research. Clinical obstetrics & gynaecology·2024
Same author

Ethical preparedness in genomic medicine: how NHS clinical scientists navigate ethical issues.

Journal of medical ethics·2024
Same journal

Science and Society: Pathways to Equitable Access and Delivery of Genomics Medicine in Africa.

Current genetic medicine reports·2025
Same journal

Benefits and Challenges of Rare Genetic Variation in Alzheimer's Disease.

Current genetic medicine reports·2024
Same journal

Expanding Use of cfDNA Screening in Pregnancy: Current and Emerging Ethical, Legal, and Social Issues.

Current genetic medicine reports·2023
Same journal

Genetic, Social, and Lifestyle Drivers of Healthy Aging and Longevity.

Current genetic medicine reports·2023
Same journal

Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk.

Current genetic medicine reports·2021
Same journal

Horizon Scanning in Cancer Genomics: How Advances in Genomic Medicine Will Change Cancer Care Over the Next Decade.

Current genetic medicine reports·2021
See all related articles

Related Experiment Video

Updated: Aug 26, 2025

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.1K

Genodermatoses - Opportunities for Early Detection and Cancer Prevention.

Helena Carley1, Anjana Kulkarni1

  • 1Guy's Regional Genetics Service, Great Maze Pond, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT UK.

Current Genetic Medicine Reports
|October 10, 2022
PubMed
Summary
This summary is machine-generated.

This review highlights the clinical signs of adult-onset genodermatosis-associated hereditary cancer predisposition syndromes. Early recognition of these rare genetic conditions aids in implementing crucial risk-reduction strategies.

Keywords:
Cancer riskCancer susceptibilityGenodermatosesHereditary cancerInherited skin

More Related Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

1.7K

Related Experiment Videos

Last Updated: Aug 26, 2025

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.1K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

1.7K

Area of Science:

  • Dermatology
  • Genetics
  • Oncology

Background:

  • Adult-onset genodermatosis-associated hereditary cancer predisposition syndromes are challenging to diagnose due to diverse clinical presentations.
  • These rare genetic conditions require multidisciplinary expertise for accurate identification.

Purpose of the Study:

  • To review the clinical features of major adult-onset genodermatosis-associated hereditary cancer predisposition syndromes.
  • To guide clinicians in identifying potential cases through cutaneous and non-malignant signs.
  • To propose triage criteria for remote consultations in cancer genetics services.

Main Methods:

  • Literature review of genodermatosis-associated hereditary cancer predisposition syndromes.
  • Emphasis on non-malignant and cutaneous manifestations.
  • Development of triage criteria for remote patient assessment.

Main Results:

  • Genodermatosis-associated hereditary cancer syndromes present with a wide spectrum of clinical features.
  • Cutaneous and non-malignant findings can serve as crucial diagnostic clues.
  • Proposed triage criteria can facilitate remote identification of at-risk patients.

Conclusions:

  • Increased clinician awareness of genodermatosis-associated hereditary cancer predisposition syndromes is vital.
  • Early diagnosis enables timely implementation of cancer risk-reduction measures.
  • The proposed triage criteria support efficient patient management in genetics services.